APO Research
Talk to an analyst

APO RESEARCH · REPORT

Compounding Pharmacy

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:

A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.

A person may be allergic to one of the ingredients in the commercial version of a drug.

A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.

Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.

Selected research

Market Structure

Global Compounding Pharmacy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchCompounding Pharmacy Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Compounding Pharmacy Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Compounding Pharmacy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Compounding Pharmacy Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Compounding Pharmacy Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:

A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.

A person may be allergic to one of the ingredients in the commercial version of a drug.

Read the full market overview

A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.

Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.

Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%.

North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.

In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.

Report Includes

This report provides an overview of the global Compounding Pharmacy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Compounding Pharmacy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Compounding Pharmacy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Compounding Pharmacy market size, projected growth trends, production technologies, key applications, and end-use industries.

Compounding Pharmacy Segment by Company

PharMEDium Services

B. Braun Group

Fagron

Wedgewood Pharmacy

New Compounding Pharma

Medisca

Fresenius Kabi

Advanced Pharma

AIN GROUP

Nihon Chouzai

Sogo Medical

Dougherty’s Pharmacy

Apollo Pharmacy

Downing Labs

Qol Holdings

Olympia Pharmacy

PUMCH

Triangle Compounding Pharmacy

Peking University First Hospital

Affiliated Hospital of Guangdong Public Institution of Medicine

Lorraine's Pharmacy

PLAGH

Institutional Pharmacy Solutions

Ruijin Hospital

Belle Sante

Byculla Pharmacy&Stores

Royal Chemists

Village Compounding Pharmacy

Specialist Pharmacy

Compounding Pharmacy Segment by Type

PIA

PAA

CUPM

PDA

SAPM

Compounding Pharmacy Segment by Application

Consumers Aged 18 and Younger

Consumers Aged 19 to 44

Consumers Aged 45 to 64

Consumers Aged 65 and Older

Compounding Pharmacy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounding Pharmacy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Compounding Pharmacy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounding Pharmacy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Compounding Pharmacy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Compounding Pharmacy industry.

Chapter 3: Detailed analysis of Compounding Pharmacy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Compounding Pharmacyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Compounding Pharmacy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of PIA Table 3. Key Players of PAA Table 4. Key Players of CUPM Table 3. Key Players of PDA Table 4. Key Players of SAPM Table 5. Global Compounding Pharmacy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Consumers Aged 18 and Younger Table 7. Key Players of Consumers Aged 19 to 44 Table 8. Key Players of Consumers Aged 45 to 64 Table 9. Key Players of Consumers Aged 65 and Older Table 10. Global Compounding Pharmacy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Compounding Pharmacy Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Compounding Pharmacy Market Share by Region (2021-2026) Table 13. Global Compounding Pharmacy Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Compounding Pharmacy Market Share by Region (2027-2032) Table 15. Compounding Pharmacy Industry Trends Table 16. Compounding Pharmacy Industry Drivers Table 17. Compounding Pharmacy Industry Opportunities and Challenges Table 18. Compounding Pharmacy Industry Restraints Table 19. Global Compounding Pharmacy Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Compounding Pharmacy Revenue Market Share by Company (2021-2026) Table 21. Global Compounding Pharmacy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Compounding Pharmacy Key Company Head Office and Area Served Table 23. Global Compounding Pharmacy Company, Product Type & Application Table 24. Global Compounding Pharmacy Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Compounding Pharmacy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Compounding Pharmacy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Compounding Pharmacy Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Compounding Pharmacy Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Compounding Pharmacy Revenue Market Share by Type (2021-2026) Table 31. Global Compounding Pharmacy Revenue Market Share by Type (2027-2032) Table 32. Global Compounding Pharmacy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Compounding Pharmacy Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Compounding Pharmacy Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Compounding Pharmacy Revenue Market Share by Application (2021-2026) Table 36. Global Compounding Pharmacy Revenue Market Share by Application (2027-2032) Table 37. PharMEDium Services Company Information Table 38. PharMEDium Services Business Overview Table 39. PharMEDium Services Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. PharMEDium Services Compounding Pharmacy Product Portfolio Table 41. PharMEDium Services Recent Development Table 42. B. Braun Group Company Information Table 43. B. Braun Group Business Overview Table 44. B. Braun Group Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. B. Braun Group Compounding Pharmacy Product Portfolio Table 46. B. Braun Group Recent Development Table 47. Fagron Company Information Table 48. Fagron Business Overview Table 49. Fagron Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Fagron Compounding Pharmacy Product Portfolio Table 51. Fagron Recent Development Table 52. Wedgewood Pharmacy Company Information Table 53. Wedgewood Pharmacy Business Overview Table 54. Wedgewood Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Wedgewood Pharmacy Compounding Pharmacy Product Portfolio Table 56. Wedgewood Pharmacy Recent Development Table 57. New Compounding Pharma Company Information Table 58. New Compounding Pharma Business Overview Table 59. New Compounding Pharma Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. New Compounding Pharma Compounding Pharmacy Product Portfolio Table 61. New Compounding Pharma Recent Development Table 62. Medisca Company Information Table 63. Medisca Business Overview Table 64. Medisca Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Medisca Compounding Pharmacy Product Portfolio Table 66. Medisca Recent Development Table 67. Fresenius Kabi Company Information Table 68. Fresenius Kabi Business Overview Table 69. Fresenius Kabi Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Fresenius Kabi Compounding Pharmacy Product Portfolio Table 71. Fresenius Kabi Recent Development Table 72. Advanced Pharma Company Information Table 73. Advanced Pharma Business Overview Table 74. Advanced Pharma Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Advanced Pharma Compounding Pharmacy Product Portfolio Table 76. Advanced Pharma Recent Development Table 77. AIN GROUP Company Information Table 78. AIN GROUP Business Overview Table 79. AIN GROUP Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. AIN GROUP Compounding Pharmacy Product Portfolio Table 81. AIN GROUP Recent Development Table 82. Nihon Chouzai Company Information Table 83. Nihon Chouzai Business Overview Table 84. Nihon Chouzai Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Nihon Chouzai Compounding Pharmacy Product Portfolio Table 86. Nihon Chouzai Recent Development Table 87. Sogo Medical Company Information Table 88. Sogo Medical Business Overview Table 89. Sogo Medical Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Sogo Medical Compounding Pharmacy Product Portfolio Table 91. Sogo Medical Recent Development Table 92. Dougherty’s Pharmacy Company Information Table 93. Dougherty’s Pharmacy Business Overview Table 94. Dougherty’s Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Dougherty’s Pharmacy Compounding Pharmacy Product Portfolio Table 96. Dougherty’s Pharmacy Recent Development Table 97. Apollo Pharmacy Company Information Table 98. Apollo Pharmacy Business Overview Table 99. Apollo Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Apollo Pharmacy Compounding Pharmacy Product Portfolio Table 101. Apollo Pharmacy Recent Development Table 102. Downing Labs Company Information Table 103. Downing Labs Business Overview Table 104. Downing Labs Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Downing Labs Compounding Pharmacy Product Portfolio Table 106. Downing Labs Recent Development Table 107. Qol Holdings Company Information Table 108. Qol Holdings Business Overview Table 109. Qol Holdings Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Qol Holdings Compounding Pharmacy Product Portfolio Table 111. Qol Holdings Recent Development Table 112. Olympia Pharmacy Company Information Table 113. Olympia Pharmacy Business Overview Table 114. Olympia Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Olympia Pharmacy Compounding Pharmacy Product Portfolio Table 116. Olympia Pharmacy Recent Development Table 117. PUMCH Company Information Table 118. PUMCH Business Overview Table 119. PUMCH Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. PUMCH Compounding Pharmacy Product Portfolio Table 121. PUMCH Recent Development Table 122. Triangle Compounding Pharmacy Company Information Table 123. Triangle Compounding Pharmacy Business Overview Table 124. Triangle Compounding Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. Triangle Compounding Pharmacy Compounding Pharmacy Product Portfolio Table 126. Triangle Compounding Pharmacy Recent Development Table 127. Peking University First Hospital Company Information Table 128. Peking University First Hospital Business Overview Table 129. Peking University First Hospital Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. Peking University First Hospital Compounding Pharmacy Product Portfolio Table 131. Peking University First Hospital Recent Development Table 132. Affiliated Hospital of Guangdong Public Institution of Medicine Company Information Table 133. Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview Table 134. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Product Portfolio Table 136. Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development Table 137. Lorraine's Pharmacy Company Information Table 138. Lorraine's Pharmacy Business Overview Table 139. Lorraine's Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 140. Lorraine's Pharmacy Compounding Pharmacy Product Portfolio Table 141. Lorraine's Pharmacy Recent Development Table 142. PLAGH Company Information Table 143. PLAGH Business Overview Table 144. PLAGH Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 145. PLAGH Compounding Pharmacy Product Portfolio Table 146. PLAGH Recent Development Table 147. Institutional Pharmacy Solutions Company Information Table 148. Institutional Pharmacy Solutions Business Overview Table 149. Institutional Pharmacy Solutions Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 150. Institutional Pharmacy Solutions Compounding Pharmacy Product Portfolio Table 151. Institutional Pharmacy Solutions Recent Development Table 152. Ruijin Hospital Company Information Table 153. Ruijin Hospital Business Overview Table 154. Ruijin Hospital Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 155. Ruijin Hospital Compounding Pharmacy Product Portfolio Table 156. Ruijin Hospital Recent Development Table 157. Belle Sante Company Information Table 158. Belle Sante Business Overview Table 159. Belle Sante Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 160. Belle Sante Compounding Pharmacy Product Portfolio Table 161. Belle Sante Recent Development Table 162. Byculla Pharmacy&Stores Company Information Table 163. Byculla Pharmacy&Stores Business Overview Table 164. Byculla Pharmacy&Stores Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 165. Byculla Pharmacy&Stores Compounding Pharmacy Product Portfolio Table 166. Byculla Pharmacy&Stores Recent Development Table 167. Royal Chemists Company Information Table 168. Royal Chemists Business Overview Table 169. Royal Chemists Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 170. Royal Chemists Compounding Pharmacy Product Portfolio Table 171. Royal Chemists Recent Development Table 172. Village Compounding Pharmacy Company Information Table 173. Village Compounding Pharmacy Business Overview Table 174. Village Compounding Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 175. Village Compounding Pharmacy Compounding Pharmacy Product Portfolio Table 176. Village Compounding Pharmacy Recent Development Table 177. Specialist Pharmacy Company Information Table 178. Specialist Pharmacy Business Overview Table 179. Specialist Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 180. Specialist Pharmacy Compounding Pharmacy Product Portfolio Table 181. Specialist Pharmacy Recent Development Table 182. North America Compounding Pharmacy Market Size by Type (2021-2026) & (US$ Million) Table 183. North America Compounding Pharmacy Market Size by Type (2027-2032) & (US$ Million) Table 184. North America Compounding Pharmacy Market Size by Application (2021-2026) & (US$ Million) Table 185. North America Compounding Pharmacy Market Size by Application (2027-2032) & (US$ Million) Table 186. North America Compounding Pharmacy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. North America Compounding Pharmacy Market Size by Country (2021-2026) Table 188. North America Compounding Pharmacy Market Size by Country (2027-2032) Table 189. Europe Compounding Pharmacy Market Size by Type (2021-2026) & (US$ Million) Table 190. Europe Compounding Pharmacy Market Size by Type (2027-2032) & (US$ Million) Table 191. Europe Compounding Pharmacy Market Size by Application (2021-2026) & (US$ Million) Table 192. Europe Compounding Pharmacy Market Size by Application (2027-2032) & (US$ Million) Table 193. Europe Compounding Pharmacy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Compounding Pharmacy Market Size by Country (2021-2026) Table 195. Europe Compounding Pharmacy Market Size by Country (2027-2032) Table 196. China Compounding Pharmacy Market Size by Type (2021-2026) & (US$ Million) Table 197. China Compounding Pharmacy Market Size by Type (2027-2032) & (US$ Million) Table 198. China Compounding Pharmacy Market Size by Application (2021-2026) & (US$ Million) Table 199. China Compounding Pharmacy Market Size by Application (2027-2032) & (US$ Million) Table 200. Asia Compounding Pharmacy Market Size by Type (2021-2026) & (US$ Million) Table 201. Asia Compounding Pharmacy Market Size by Type (2027-2032) & (US$ Million) Table 202. Asia Compounding Pharmacy Market Size by Application (2021-2026) & (US$ Million) Table 203. Asia Compounding Pharmacy Market Size by Application (2027-2032) & (US$ Million) Table 204. Asia Compounding Pharmacy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Asia Compounding Pharmacy Market Size by Country (2021-2026) Table 206. Asia Compounding Pharmacy Market Size by Country (2027-2032) Table 207. South America, Middle East & Africa Compounding Pharmacy Market Size by Type (2021-2026) & (US$ Million) Table 208. South America, Middle East & Africa Compounding Pharmacy Market Size by Type (2027-2032) & (US$ Million) Table 209. South America, Middle East & Africa Compounding Pharmacy Market Size by Application (2021-2026) & (US$ Million) Table 210. South America, Middle East & Africa Compounding Pharmacy Market Size by Application (2027-2032) & (US$ Million) Table 211. South America, Middle East & Africa Compounding Pharmacy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. South America, Middle East & Africa Compounding Pharmacy Market Size by Country (2021-2026) Table 213. South America, Middle East & Africa Compounding Pharmacy Market Size by Country (2027-2032) Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Compounding Pharmacy Product Image Figure 2. Global Compounding Pharmacy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Compounding Pharmacy Market Share by Type: 2025 VS 2032 Figure 4. PIA Image Figure 5. PAA Image Figure 6. CUPM Image Figure 7. PDA Image Figure 8. SAPM Image Figure 9. Global Compounding Pharmacy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Compounding Pharmacy Market Share by Application: 2025 VS 2032 Figure 11. Consumers Aged 18 and Younger Image Figure 12. Consumers Aged 19 to 44 Image Figure 13. Consumers Aged 45 to 64 Image Figure 14. Consumers Aged 65 and Older Image Figure 15. Global Compounding Pharmacy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 17. Global Compounding Pharmacy Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Compounding Pharmacy Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Compounding Pharmacy Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Compounding Pharmacy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Compounding Pharmacy Revenue Market Share by Type (2021-2032) Figure 24. Global Compounding Pharmacy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Compounding Pharmacy Revenue Market Share by Application (2021-2032) Figure 26. North America Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 27. North America Compounding Pharmacy Market Share by Type (2021-2032) Figure 28. North America Compounding Pharmacy Market Share by Application (2021-2032) Figure 29. North America Compounding Pharmacy Market Share by Country (2021-2032) Figure 30. United States Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 31. Canada Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 33. Europe Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 34. Europe Compounding Pharmacy Market Share by Type (2021-2032) Figure 35. Europe Compounding Pharmacy Market Share by Application (2021-2032) Figure 36. Europe Compounding Pharmacy Market Share by Country (2021-2032) Figure 37. Germany Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 38. France Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 40. Italy Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 41. Russia Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 43. China Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 44. China Compounding Pharmacy Market Share by Type (2021-2032) Figure 45. China Compounding Pharmacy Market Share by Application (2021-2032) Figure 46. Asia Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 47. Asia Compounding Pharmacy Market Share by Type (2021-2032) Figure 48. Asia Compounding Pharmacy Market Share by Application (2021-2032) Figure 49. Asia Compounding Pharmacy Market Share by Country (2021-2032) Figure 50. Japan Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 54. India Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 55. Australia Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Compounding Pharmacy Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Compounding Pharmacy Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Compounding Pharmacy Market Share by Country (2021-2032) Figure 60. Brazil Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 65. UAE Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 67. Chile Compounding Pharmacy Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • PIA
  • PAA
  • CUPM
  • PDA
  • SAPM
Applications
  • Consumers Aged 18 and Younger
  • Consumers Aged 19 to 44
  • Consumers Aged 45 to 64
  • Consumers Aged 65 and Older
Companies covered
  • PharMEDium Services
  • B. Braun Group
  • Fagron
  • Wedgewood Pharmacy
  • New Compounding Pharma
  • Medisca
  • Fresenius Kabi
  • Advanced Pharma
  • AIN GROUP
  • Nihon Chouzai
  • Sogo Medical
  • Dougherty’s Pharmacy
  • Apollo Pharmacy
  • Downing Labs
  • Qol Holdings
  • Olympia Pharmacy
  • PUMCH
  • Triangle Compounding Pharmacy
  • Peking University First Hospital
  • Affiliated Hospital of Guangdong Public Institution of Medicine
  • Lorraine's Pharmacy
  • PLAGH
  • Institutional Pharmacy Solutions
  • Ruijin Hospital
  • Belle Sante
  • Byculla Pharmacy&Stores
  • Royal Chemists
  • Village Compounding Pharmacy
  • Specialist Pharmacy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Compounding Pharmacy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 PIA
  5. 1.2.3 PAA
  6. 1.2.4 CUPM
  7. 1.2.5 PDA
  8. 1.2.6 SAPM
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Compounding Pharmacy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Consumers Aged 18 and Younger
  12. 1.3.3 Consumers Aged 19 to 44
  13. 1.3.4 Consumers Aged 45 to 64
  14. 1.3.5 Consumers Aged 65 and Older
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Compounding Pharmacy Growth Trends by Region
  17. 1.5.1 Global Compounding Pharmacy Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Compounding Pharmacy Market Size by Region (2021-2026)
  19. 1.5.3 Compounding Pharmacy Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Compounding Pharmacy Market Dynamics
  1. 2.1 Compounding Pharmacy Industry Trends
  2. 2.2 Compounding Pharmacy Industry Drivers
  3. 2.3 Compounding Pharmacy Industry Opportunities and Challenges
  4. 2.4 Compounding Pharmacy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Compounding Pharmacy Revenue by Company (2021-2026)
  2. 3.2 Global Compounding Pharmacy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Compounding Pharmacy Key Company Head office and Area Served
  4. 3.4 Global Compounding Pharmacy Company, Product Type & Application
  5. 3.5 Global Compounding Pharmacy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Compounding Pharmacy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Compounding Pharmacy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Compounding Pharmacy Tier 1, Tier 2, and Tier 3
4 Compounding Pharmacy Market by Type
  1. 4.1 Global Compounding Pharmacy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Compounding Pharmacy Market Size by Type (2021-2032)
  3. 4.3 Global Compounding Pharmacy Market Size Share by Type (2021-2032)
5 Compounding Pharmacy Market by Application
  1. 5.1 Global Compounding Pharmacy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Compounding Pharmacy Market Size by Application (2021-2032)
  3. 5.3 Global Compounding Pharmacy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 PharMEDium Services
  2. 6.1.1 PharMEDium Services Company Information
  3. 6.1.2 PharMEDium Services Business Overview
  4. 6.1.3 PharMEDium Services Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 PharMEDium Services Compounding Pharmacy Product Portfolio
  6. 6.1.5 PharMEDium Services Recent Developments
  7. 6.2 B. Braun Group
  8. 6.2.1 B. Braun Group Company Information
  9. 6.2.2 B. Braun Group Business Overview
  10. 6.2.3 B. Braun Group Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 B. Braun Group Compounding Pharmacy Product Portfolio
  12. 6.2.5 B. Braun Group Recent Developments
  13. 6.3 Fagron
  14. 6.3.1 Fagron Company Information
  15. 6.3.2 Fagron Business Overview
  16. 6.3.3 Fagron Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Fagron Compounding Pharmacy Product Portfolio
  18. 6.3.5 Fagron Recent Developments
  19. 6.4 Wedgewood Pharmacy
  20. 6.4.1 Wedgewood Pharmacy Company Information
  21. 6.4.2 Wedgewood Pharmacy Business Overview
  22. 6.4.3 Wedgewood Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Wedgewood Pharmacy Compounding Pharmacy Product Portfolio
  24. 6.4.5 Wedgewood Pharmacy Recent Developments
  25. 6.5 New Compounding Pharma
  26. 6.5.1 New Compounding Pharma Company Information
  27. 6.5.2 New Compounding Pharma Business Overview
  28. 6.5.3 New Compounding Pharma Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 New Compounding Pharma Compounding Pharmacy Product Portfolio
  30. 6.5.5 New Compounding Pharma Recent Developments
  31. 6.6 Medisca
  32. 6.6.1 Medisca Company Information
  33. 6.6.2 Medisca Business Overview
  34. 6.6.3 Medisca Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Medisca Compounding Pharmacy Product Portfolio
  36. 6.6.5 Medisca Recent Developments
  37. 6.7 Fresenius Kabi
  38. 6.7.1 Fresenius Kabi Company Information
  39. 6.7.2 Fresenius Kabi Business Overview
  40. 6.7.3 Fresenius Kabi Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Fresenius Kabi Compounding Pharmacy Product Portfolio
  42. 6.7.5 Fresenius Kabi Recent Developments
  43. 6.8 Advanced Pharma
  44. 6.8.1 Advanced Pharma Company Information
  45. 6.8.2 Advanced Pharma Business Overview
  46. 6.8.3 Advanced Pharma Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Advanced Pharma Compounding Pharmacy Product Portfolio
  48. 6.8.5 Advanced Pharma Recent Developments
  49. 6.9 AIN GROUP
  50. 6.9.1 AIN GROUP Company Information
  51. 6.9.2 AIN GROUP Business Overview
  52. 6.9.3 AIN GROUP Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AIN GROUP Compounding Pharmacy Product Portfolio
  54. 6.9.5 AIN GROUP Recent Developments
  55. 6.10 Nihon Chouzai
  56. 6.10.1 Nihon Chouzai Company Information
  57. 6.10.2 Nihon Chouzai Business Overview
  58. 6.10.3 Nihon Chouzai Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Nihon Chouzai Compounding Pharmacy Product Portfolio
  60. 6.10.5 Nihon Chouzai Recent Developments
  61. 6.11 Sogo Medical
  62. 6.11.1 Sogo Medical Company Information
  63. 6.11.2 Sogo Medical Business Overview
  64. 6.11.3 Sogo Medical Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sogo Medical Compounding Pharmacy Product Portfolio
  66. 6.11.5 Sogo Medical Recent Developments
  67. 6.12 Dougherty’s Pharmacy
  68. 6.12.1 Dougherty’s Pharmacy Company Information
  69. 6.12.2 Dougherty’s Pharmacy Business Overview
  70. 6.12.3 Dougherty’s Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Dougherty’s Pharmacy Compounding Pharmacy Product Portfolio
  72. 6.12.5 Dougherty’s Pharmacy Recent Developments
  73. 6.13 Apollo Pharmacy
  74. 6.13.1 Apollo Pharmacy Company Information
  75. 6.13.2 Apollo Pharmacy Business Overview
  76. 6.13.3 Apollo Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Apollo Pharmacy Compounding Pharmacy Product Portfolio
  78. 6.13.5 Apollo Pharmacy Recent Developments
  79. 6.14 Downing Labs
  80. 6.14.1 Downing Labs Company Information
  81. 6.14.2 Downing Labs Business Overview
  82. 6.14.3 Downing Labs Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Downing Labs Compounding Pharmacy Product Portfolio
  84. 6.14.5 Downing Labs Recent Developments
  85. 6.15 Qol Holdings
  86. 6.15.1 Qol Holdings Company Information
  87. 6.15.2 Qol Holdings Business Overview
  88. 6.15.3 Qol Holdings Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Qol Holdings Compounding Pharmacy Product Portfolio
  90. 6.15.5 Qol Holdings Recent Developments
  91. 6.16 Olympia Pharmacy
  92. 6.16.1 Olympia Pharmacy Company Information
  93. 6.16.2 Olympia Pharmacy Business Overview
  94. 6.16.3 Olympia Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Olympia Pharmacy Compounding Pharmacy Product Portfolio
  96. 6.16.5 Olympia Pharmacy Recent Developments
  97. 6.17 PUMCH
  98. 6.17.1 PUMCH Company Information
  99. 6.17.2 PUMCH Business Overview
  100. 6.17.3 PUMCH Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 PUMCH Compounding Pharmacy Product Portfolio
  102. 6.17.5 PUMCH Recent Developments
  103. 6.18 Triangle Compounding Pharmacy
  104. 6.18.1 Triangle Compounding Pharmacy Company Information
  105. 6.18.2 Triangle Compounding Pharmacy Business Overview
  106. 6.18.3 Triangle Compounding Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Triangle Compounding Pharmacy Compounding Pharmacy Product Portfolio
  108. 6.18.5 Triangle Compounding Pharmacy Recent Developments
  109. 6.19 Peking University First Hospital
  110. 6.19.1 Peking University First Hospital Company Information
  111. 6.19.2 Peking University First Hospital Business Overview
  112. 6.19.3 Peking University First Hospital Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Peking University First Hospital Compounding Pharmacy Product Portfolio
  114. 6.19.5 Peking University First Hospital Recent Developments
  115. 6.20 Affiliated Hospital of Guangdong Public Institution of Medicine
  116. 6.20.1 Affiliated Hospital of Guangdong Public Institution of Medicine Company Information
  117. 6.20.2 Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
  118. 6.20.3 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Product Portfolio
  120. 6.20.5 Affiliated Hospital of Guangdong Public Institution of Medicine Recent Developments
  121. 6.21 Lorraine's Pharmacy
  122. 6.21.1 Lorraine's Pharmacy Company Information
  123. 6.21.2 Lorraine's Pharmacy Business Overview
  124. 6.21.3 Lorraine's Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Lorraine's Pharmacy Compounding Pharmacy Product Portfolio
  126. 6.21.5 Lorraine's Pharmacy Recent Developments
  127. 6.22 PLAGH
  128. 6.22.1 PLAGH Company Information
  129. 6.22.2 PLAGH Business Overview
  130. 6.22.3 PLAGH Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 PLAGH Compounding Pharmacy Product Portfolio
  132. 6.22.5 PLAGH Recent Developments
  133. 6.23 Institutional Pharmacy Solutions
  134. 6.23.1 Institutional Pharmacy Solutions Company Information
  135. 6.23.2 Institutional Pharmacy Solutions Business Overview
  136. 6.23.3 Institutional Pharmacy Solutions Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Institutional Pharmacy Solutions Compounding Pharmacy Product Portfolio
  138. 6.23.5 Institutional Pharmacy Solutions Recent Developments
  139. 6.24 Ruijin Hospital
  140. 6.24.1 Ruijin Hospital Company Information
  141. 6.24.2 Ruijin Hospital Business Overview
  142. 6.24.3 Ruijin Hospital Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Ruijin Hospital Compounding Pharmacy Product Portfolio
  144. 6.24.5 Ruijin Hospital Recent Developments
  145. 6.25 Belle Sante
  146. 6.25.1 Belle Sante Company Information
  147. 6.25.2 Belle Sante Business Overview
  148. 6.25.3 Belle Sante Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Belle Sante Compounding Pharmacy Product Portfolio
  150. 6.25.5 Belle Sante Recent Developments
  151. 6.26 Byculla Pharmacy&Stores
  152. 6.26.1 Byculla Pharmacy&Stores Company Information
  153. 6.26.2 Byculla Pharmacy&Stores Business Overview
  154. 6.26.3 Byculla Pharmacy&Stores Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 Byculla Pharmacy&Stores Compounding Pharmacy Product Portfolio
  156. 6.26.5 Byculla Pharmacy&Stores Recent Developments
  157. 6.27 Royal Chemists
  158. 6.27.1 Royal Chemists Company Information
  159. 6.27.2 Royal Chemists Business Overview
  160. 6.27.3 Royal Chemists Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  161. 6.27.4 Royal Chemists Compounding Pharmacy Product Portfolio
  162. 6.27.5 Royal Chemists Recent Developments
  163. 6.28 Village Compounding Pharmacy
  164. 6.28.1 Village Compounding Pharmacy Company Information
  165. 6.28.2 Village Compounding Pharmacy Business Overview
  166. 6.28.3 Village Compounding Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  167. 6.28.4 Village Compounding Pharmacy Compounding Pharmacy Product Portfolio
  168. 6.28.5 Village Compounding Pharmacy Recent Developments
  169. 6.29 Specialist Pharmacy
  170. 6.29.1 Specialist Pharmacy Company Information
  171. 6.29.2 Specialist Pharmacy Business Overview
  172. 6.29.3 Specialist Pharmacy Compounding Pharmacy Revenue and Gross Margin (US$ Million) & (2021-2026)
  173. 6.29.4 Specialist Pharmacy Compounding Pharmacy Product Portfolio
  174. 6.29.5 Specialist Pharmacy Recent Developments
7 North America
  1. 7.1 North America Compounding Pharmacy Market Size (2021-2032)
  2. 7.2 North America Compounding Pharmacy Market Size by Type
  3. 7.2.1 North America Compounding Pharmacy Market Size by Type (2021-2026)
  4. 7.2.2 North America Compounding Pharmacy Market Size by Type (2027-2032)
  5. 7.2.3 North America Compounding Pharmacy Market Share by Type (2021-2032)
  6. 7.3 North America Compounding Pharmacy Market Size by Application
  7. 7.3.1 North America Compounding Pharmacy Market Size by Application (2021-2026)
  8. 7.3.2 North America Compounding Pharmacy Market Size by Application (2027-2032)
  9. 7.3.3 North America Compounding Pharmacy Market Share by Application (2021-2032)
  10. 7.4 North America Compounding Pharmacy Market Size by Country
  11. 7.4.1 North America Compounding Pharmacy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Compounding Pharmacy Market Size by Country (2021-2026)
  13. 7.4.3 North America Compounding Pharmacy Market Size by Country (2027-2032)
  14. 7.4.4 North America Compounding Pharmacy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Compounding Pharmacy Market Size (2021-2032)
  2. 8.2 Europe Compounding Pharmacy Market Size by Type
  3. 8.2.1 Europe Compounding Pharmacy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Compounding Pharmacy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Compounding Pharmacy Market Share by Type (2021-2032)
  6. 8.3 Europe Compounding Pharmacy Market Size by Application
  7. 8.3.1 Europe Compounding Pharmacy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Compounding Pharmacy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Compounding Pharmacy Market Share by Application (2021-2032)
  10. 8.4 Europe Compounding Pharmacy Market Size by Country
  11. 8.4.1 Europe Compounding Pharmacy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Compounding Pharmacy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Compounding Pharmacy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Compounding Pharmacy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Compounding Pharmacy Market Size (2021-2032)
  2. 9.2 China Compounding Pharmacy Market Size by Type
  3. 9.2.1 China Compounding Pharmacy Market Size by Type (2021-2026)
  4. 9.2.2 China Compounding Pharmacy Market Size by Type (2027-2032)
  5. 9.2.3 China Compounding Pharmacy Market Share by Type (2021-2032)
  6. 9.3 China Compounding Pharmacy Market Size by Application
  7. 9.3.1 China Compounding Pharmacy Market Size by Application (2021-2026)
  8. 9.3.2 China Compounding Pharmacy Market Size by Application (2027-2032)
  9. 9.3.3 China Compounding Pharmacy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Compounding Pharmacy Market Size (2021-2032)
  2. 10.2 Asia Compounding Pharmacy Market Size by Type
  3. 10.2.1 Asia Compounding Pharmacy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Compounding Pharmacy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Compounding Pharmacy Market Share by Type (2021-2032)
  6. 10.3 Asia Compounding Pharmacy Market Size by Application
  7. 10.3.1 Asia Compounding Pharmacy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Compounding Pharmacy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Compounding Pharmacy Market Share by Application (2021-2032)
  10. 10.4 Asia Compounding Pharmacy Market Size by Country
  11. 10.4.1 Asia Compounding Pharmacy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Compounding Pharmacy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Compounding Pharmacy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Compounding Pharmacy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Compounding Pharmacy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Compounding Pharmacy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Compounding Pharmacy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Compounding Pharmacy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Compounding Pharmacy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Compounding Pharmacy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Compounding Pharmacy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Compounding Pharmacy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Compounding Pharmacy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Compounding Pharmacy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Compounding Pharmacy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Compounding Pharmacy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Compounding Pharmacy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Compounding Pharmacy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst